Skip to main content
. 2022 Jun 2;13:780383. doi: 10.3389/fpsyg.2022.780383

Table 2.

Demographic/baseline data.

Variable Full Sample Pilot Sample
(n = 18) (n = 11)
Male N (%) 13 (72.2) 9 (81.8)
Age (years), mean (SD) 47.4 (12.8) 48.3 (15.4)
Race, N (%)
White 17 (94.4) 11 (100.0)
Other 1 (5.6) 0 (0.0)
Ethnicity Hispanic, N (%) 1 (5.6) 0 (0.0)
Lifetime Substance Use in Years, mean (SD)
Opioids 6.8 (7.4)1 9.1 (8.0)
Cannabinoids 16.9 (14.9)1 18.7 (13.9)
Cocaine 9.5 (12.5)1 11.1 (13.9)
Alcohol 8.7 (11.1)1 10.7 (11.7)
ACE score 4+, N (%) 10 (55.6)2 5 (45.5)
Non-substance use DSM-V diagnoses, N (%)
Single DSM-V diagnoses 2 (11.1) 1 (9.0)
2+ DSM-V diagnoses 16 (88.9) 10 (91.0)
Comorbid DSM-V diagnosis, N (%)
Major depressive disorder 8 (44.4) 6 (54.5)
Anxiety disorder 11 (61.1) 6 (54.5)
PTSD 4 (22.2) 2 (18.2)
Have practice meditation before, N (%) 8 (44.4) 4 (36.4)
1

Missing (N = 2).

2

Missing (N = 1).